AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis

Europe • Euronext Oslo • OSL:AKBM • NO0010886625

93.9 NOK
+1.8 (+1.95%)
Last: Feb 10, 2026, 03:52 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AKBM. AKBM was compared to 62 industry peers in the Food Products industry. AKBM may be in some trouble as it scores bad on both profitability and health. AKBM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year AKBM has reported negative net income.
  • In the past year AKBM had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.
  • AKBM had a positive operating cash flow in 4 of the past 5 years.
AKBM.OL Yearly Net Income VS EBIT VS OCF VS FCFAKBM.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

  • AKBM has a Return On Assets of -8.56%. This is amonst the worse of the industry: AKBM underperforms 87.10% of its industry peers.
  • The Return On Equity of AKBM (-22.75%) is worse than 87.10% of its industry peers.
  • AKBM has a Return On Invested Capital of 2.36%. This is in the lower half of the industry: AKBM underperforms 70.97% of its industry peers.
Industry RankSector Rank
ROA -8.56%
ROE -22.75%
ROIC 2.36%
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
AKBM.OL Yearly ROA, ROE, ROICAKBM.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

1.3 Margins

  • AKBM has a Operating Margin (3.69%) which is in line with its industry peers.
  • The Gross Margin of AKBM (45.65%) is better than 67.74% of its industry peers.
  • AKBM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 45.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
AKBM.OL Yearly Profit, Operating, Gross MarginsAKBM.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKBM is destroying value.
  • The number of shares outstanding for AKBM remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, AKBM has about the same amount of shares outstanding.
  • AKBM has a better debt/assets ratio than last year.
AKBM.OL Yearly Shares OutstandingAKBM.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
AKBM.OL Yearly Total Debt VS Total AssetsAKBM.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • AKBM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • AKBM has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: AKBM underperforms 75.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.28
WACC8.52%
AKBM.OL Yearly LT Debt VS Equity VS FCFAKBM.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.56 indicates that AKBM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.56, AKBM belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
  • A Quick Ratio of 1.14 indicates that AKBM should not have too much problems paying its short term obligations.
  • AKBM's Quick ratio of 1.14 is fine compared to the rest of the industry. AKBM outperforms 72.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 1.14
AKBM.OL Yearly Current Assets VS Current LiabilitesAKBM.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for AKBM have decreased strongly by -115.95% in the last year.
  • Looking at the last year, AKBM shows a small growth in Revenue. The Revenue has grown by 2.31% in the last year.
  • Measured over the past years, AKBM shows a decrease in Revenue. The Revenue has been decreasing by -4.17% on average per year.
EPS 1Y (TTM)-115.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)2.31%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%15.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 96.03% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AKBM will show a very strong growth in Revenue. The Revenue will grow by 20.59% on average per year.
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKBM.OL Yearly Revenue VS EstimatesAKBM.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
AKBM.OL Yearly EPS VS EstimatesAKBM.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • AKBM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 40.45, AKBM can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, AKBM is valued a bit more expensive than 72.58% of the companies in the same industry.
  • AKBM's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.86.
Industry RankSector Rank
PE N/A
Fwd PE 40.45
AKBM.OL Price Earnings VS Forward Price EarningsAKBM.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AKBM is valued a bit more expensive than 70.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.25
AKBM.OL Per share dataAKBM.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AKBM's earnings are expected to grow with 96.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.56%
EPS Next 3Y96.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AKBM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AKER BIOMARINE ASA

OSL:AKBM (2/10/2026, 3:52:00 PM)

93.9

+1.8 (+1.95%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-31
Earnings (Next)02-12
Inst Owners5.57%
Inst Owner ChangeN/A
Ins Owners6.14%
Ins Owner ChangeN/A
Market Cap8.24B
Revenue(TTM)265.70M
Net Income(TTM)-34.10M
Analysts77.78
Price Target86.7 (-7.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend41.4
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-5.62%
Max Revenue beat(2)1.02%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.45
P/S 3.22
P/FCF N/A
P/OCF 778.57
P/B 5.71
P/tB 28.64
EV/EBITDA 19.25
EPS(TTM)-3.58
EYN/A
EPS(NY)2.32
Fwd EY2.47%
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)0.12
OCFY0.13%
SpS29.13
BVpS16.44
TBVpS3.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.56%
ROE -22.75%
ROCE 3.06%
ROIC 2.36%
ROICexc 2.5%
ROICexgc 4.14%
OM 3.69%
PM (TTM) N/A
GM 45.65%
FCFM N/A
ROA(3y)16.04%
ROA(5y)9.26%
ROE(3y)36.62%
ROE(5y)21.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y0.36%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA 3.06
Cap/Depr 42.42%
Cap/Sales 6.85%
Interest Coverage 0.64
Cash Conversion 2.09%
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 1.14
Altman-Z N/A
F-Score4
WACC8.52%
ROIC/WACC0.28
Cap/Depr(3y)77.43%
Cap/Depr(5y)88.04%
Cap/Sales(3y)14.31%
Cap/Sales(5y)16.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y70%
EPS Next 2Y117.56%
EPS Next 3Y96.03%
EPS Next 5YN/A
Revenue 1Y (TTM)2.31%
Revenue growth 3Y-8.77%
Revenue growth 5Y-4.17%
Sales Q2Q%15.21%
Revenue Next Year-14.74%
Revenue Next 2Y-1.39%
Revenue Next 3Y2.27%
Revenue Next 5Y20.59%
EBIT growth 1Y246.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year170.83%
EBIT Next 3Y67.11%
EBIT Next 5YN/A
FCF growth 1Y14.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.56%
OCF growth 3Y155.79%
OCF growth 5Y-0.17%

AKER BIOMARINE ASA / AKBM.OL FAQ

Can you provide the ChartMill fundamental rating for AKER BIOMARINE ASA?

ChartMill assigns a fundamental rating of 3 / 10 to AKBM.OL.


Can you provide the valuation status for AKER BIOMARINE ASA?

ChartMill assigns a valuation rating of 2 / 10 to AKER BIOMARINE ASA (AKBM.OL). This can be considered as Overvalued.


Can you provide the profitability details for AKER BIOMARINE ASA?

AKER BIOMARINE ASA (AKBM.OL) has a profitability rating of 2 / 10.


How financially healthy is AKER BIOMARINE ASA?

The financial health rating of AKER BIOMARINE ASA (AKBM.OL) is 3 / 10.


What is the earnings growth outlook for AKER BIOMARINE ASA?

The Earnings per Share (EPS) of AKER BIOMARINE ASA (AKBM.OL) is expected to grow by 70% in the next year.